Abstract
Even early-treated phenylketonuric patients suffer from phenylalanine-associated (mild) neuropsychological impairment. To date it is still unclear whether patients' deficits show a progression on ageing. This unsolved question seems to be an important aspect in the still ongoing debate about how long and how strictly the patients should be maintained on diet. Twenty early-treated (20±10, 9–30 days) adolescent phenylketonurics (10 boys, 10 girls) and 20 healthy controls, matched for age, sex and IQ, were inves-tigated twice at a mean ages of 11 and 14 years for their IQ (Culture Fair Intelligence Test–Scale 2; CFT-20), fine motor abilities (Motor PerformanceTask), sustained (Test d2) and selective attention (Stroop-Task). At the first test, examinations revealed significant blood phenylalanine-correlated neuropsychological deficits in PKU patients. In spite of raised blood phenylalanine concentrations during the following 3 years and significantly elevated concurrent blood phenylalanine concentrations, the repeated measurements revealed a significant decrease of patients' deficits compared to controls. Clinical-neurological status of patients and controls was normal at both test times. The results indicate a decreased vulnerability of PKU-patients with respect to their neuropsychological functioning against elevated blood phenylalanine levels on ageing.
Similar content being viewed by others
References
APS (Stellungnahme der Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen) (1990) Diätetische Behandlung der Phenylketonurie. Monatsschr Kinderheilkd 138: 636.
Bäumler G (1985) Farbe Wort Interferenz Test (FW IT ) nach JR Stroop. Göttingen: Verlag für Psychologie, 1-75.
Bench CJ, Frith CJ, Gasby PM, Friston KJ, Frankowiak RSJ, Dolan RJ (1993) Investigations of the functional anatomy of attention using the Stroop test. Neuropsychology 31: 907-922.
Bortz J (1983) Statistik. Berlin: Springer-Verlag.
Brickenkamp R (1994) Test d 2 Aufmerksamkeits-Belastungs-Test. Göttingen: Verlag für Psychologie, 1-98.
Brunner RL, Berry HK (1987) Phenylketonuria and sustained attention: the continuous performance test. Int J Clin Neuropsychol 9: 68-70.
Burgard P, Schmidt E, Rupp A, Schneider W, Bremer HJ (1996) Intellectual development of the patients of the German Collaborative Study of patients treated for phenylketonuria. Eur J Pediatr 155 (supplement 1): 33-38.
Burgard P, Rey F, Rupp A, Abadie V, Rey J (1997) Neuropsychological functions in early treated patients with phenylketonuria on and off diet. Results of a cross-national and crosssectional study. Pediatr Res 41: 368-374.
Cleary MA, Walter JH, Wraith JE, et al (1994) Magnetic resonance imaging of the brain in phenylketonuria. Lancet 344: 87-90.
Diamond A (1994) Phenylalanine levels of 6 to 10 mg/dl may not be as benign as once thought. Acta Paediatr (Suppl) 407: 89-91.
Faust D, Libon D, Pueschel S (1986) Neuropsychological functioning in treated phenylketonuria. Int J Psychiatry Med 16: 169-177.
German Paediatric Society (1990) Stellungnahme der Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen APS zur diätetischen Behandlung der Phenylketonurie. Monatsschr Kinderheilkd 138: 636.
Griffiths P, Campbell R, Robinson P (1998) Executive function in treated phenylketonuria as measured by the one-back and two-back versions of the continuous performance task. J Inher Metab Dis 21: 125-135.
Holtzman NA, Kronmal RA, van Doorninck W, Azen C, Koch R (1986) Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria. N Engl J Med 314: 593-598.
Hommes FA (1994) Loss of neurotransmitter receptors by hyperphenylalaninemia in the MPH-5 mouse brain. Acta Paediatr (Suppl) 407: 120-121.
Huttenlocher PR (1975) Synaptic density in frontal lobe cortex: developmental stages and effects of aging. Brain Res 163: 195-205.
Kirkcaldy B (1986) Differential psychomotor skills in a clinical group. Pers Indiv Diff 7: 853-859.
Lou HC, Güttler F, Lykkelund C, Bruhn P, Niederwieser A (1985) Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents. Eur J Pediatr 144: 17-20.
Lou HC, Lykkelund C, Gerdes AM, Udesen H, Bruhn P (1987) Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria. Acta Paediatr 76: 560-565.
McKean CM (1972) The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain. Brain Res 47: 469-476.
Medical Research Council Working Party on Phenylketonuria (1993) Recommendations on the dietary management of phenylketonuria. Arch Dis Child 68: 426-427.
Milner JD, Wurtman RJ (1986) Effects of phenylalanine on the release of endogenous dopamine from rat striatal slices. J Neurochem 47: 1444-1448.
Pardo JV, Pardo PJ, Janer KW, Raichle ME (1990) The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proc Natl Acad Sci USA 87: 256-259.
Perret E (1974) The left frontal lobe of man and the suppression of habitual responses in verbal categorical behaviour. Neuropsychology 12: 323-330.
Pietz J, Fätkenheuer B, Burgard P, Armbruster M, Esser G, Schmidt H (1997) Psychiatric disorders in adult patients with early treated phenylketonuria. J Pediatr 99: 345-350.
Pratt OE (1992) Transport inhibition in the pathology of phenylketonuria and other inherited metabolic diseases. J Inher Metab Dis 2 (supplement 2): 75-81.
Quatember R, Maly J (1980) Neuropsychologische Untersuchungsmethoden altersspezifischer Leistungsparameter. Wien Med Wochenschr 30: 688-692.
Rey F, Abadie V, Plainguet F, Rey J (1996) Long-term follow up of patients with classical phenylketonuria after diet relaxation at 5 years of age. The Paris Study. Eur J Pediatr 155 (supplement 1): 39-44.
Ris MD, Weber AM, Hunt MM, Berry HK, Williams SE, Leslie N (1997) Adult psychosocial outcome in early-treated phenylketonuria. J Inher Metab Dis 20: 499-508.
Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, Sonneville de L (1994) Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine blood level. J Clin Exp Neuropsychol 16: 681-688.
Schmidt E, Burgard P, Rupp A (1996) Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria. Eur J Pediatr 155 (supplement 1): 82-88.
Schoppe KJ (1974) Das MLS-Gerät: Ein neuer Testapparat zur Messung feinmotorischer Leistungen. Diagnostica 20: 43-46.
Scriver CR, Kaufman S, Eisensmith RC, Woo SLC (1995) The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Diseases, 7th edn. New York: MacGraw-Hill, 1015-1076.
Smith I (1994) Treatment of phenylalanine hydroxylase defficiency. Acta Paediatr (Suppl) 407: 60-65.
Smith I, Beaseley MG, Ades AE (1991) Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria. Arch Dis Child 65: 311-316.
Waisbren SE, Brown MJ, Sonneville de LMJ, Levy HL (1994) Review of neuropsychological functioning in treated phenylketonuria: an information processing approach. Acta Paediatr (Suppl) 407: 98-103.
Weglage J, Fünders B, Wilken B, et al (1992) Psychological and social findings in adolescents with phenylketonuria. Eur J Pediatr 151: 522-525.
Weglage J, Fünders B, van Teefflen-Heithoff A, Ullrich K (1993) Behandlung der Phenylketonurie: Wunsch und Wirklichkeit. Monatsschr Kinderheilkd 141: 670-674.
Weglage J, Pietsch M, Fünders B, Koch HG, Ullrich K (1995) Neurological findings in early treated phenylketonuria. Acta Paediatr 84: 411-415.
Weglage J, Pietsch M, Fünders B, Koch HG, Ullrich K (1996) Deficits in selective and sustained attention processes in early treated children with phenylketonuria-result of impaired frontal lobe functions? Eur J Pediatr 155: 200-204.
Weiss RH (1987) Grundintelligenztest Skala 2 CFT 20. Göttingen: Verlag für Psychologie, pp 1-67.
Welsh MC, Pennington BF, Ozonoff S, Rouse B, McCabe ERB (1990) Neuropsychology of early treated phenylketonuria: specific executive function deficits. Child Dev 61: 1697-1713.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weglage, J., Pietsche, M., Denecke, J. et al. Regression of neuropsychological deficits in early-treated phenylketonurics during adolescence. J Inherit Metab Dis 22, 693–705 (1999). https://doi.org/10.1023/A:1005587915468
Issue Date:
DOI: https://doi.org/10.1023/A:1005587915468